A developer of catheter-based heart pump technologies used to support patients with severe coronary artery disease and cardiogenic shock. Its flagship Impella devices are used by interventional cardiologists during high‑risk percutaneous coronary interventions and critical care procedures. Investors...
Market Cap: $17.2B52W Range: $219.84 – $381.99
This page tracks all publicly disclosed congressional trades in Abiomed, Inc. (ABMD), a company in the Healthcare sector. 3 members of Congress have disclosed trades in this stock, including 7 purchases and 4 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.